Zafirlukast, Structure, Mechanism of action, Drug Interactions, Therapeutic Uses, Adverse effects and Contraindications

                                              Zafirlukast

 Zafirlukast is a medication that belongs to a class of drugs called leukotriene receptor antagonists. It is primarily used for the long-term management of asthma, particularly in patients who experience asthma symptoms despite using other medications such as inhaled corticosteroids.

Zafirlukast works by blocking the action of certain chemicals in the body called leukotrienes. Leukotrienes are substances that are released by the immune system in response to allergens or other triggers, and they cause inflammation, bronchoconstriction (narrowing of the airways), and mucus production in the lungs. By blocking the leukotriene receptors, zafirlukast helps to reduce these effects and improve asthma symptoms.

Zafirlukast is primarily available under the brand name Accolate. This is the most commonly known brand name for zafirlukast medication.

Mechanism Of Action

The MOA (mechanism of action) of zafirlukast involves its activity as a leukotriene receptor antagonist. Specifically, zafirlukast blocks the action of leukotrienes, which are inflammatory substances involved in various allergic and inflammatory conditions, including asthma. Leukotrienes are produced by cells of the immune system, particularly mast cells and eosinophils, in response to triggers such as allergens, exercise, or irritants. Once released, leukotrienes bind to specific receptors, such as the cysteinyl leukotriene receptors (CysLT1 receptors), located on various cells, including smooth muscle cells in the airways. By binding to CysLT1 receptors, leukotrienes cause airway inflammation, smooth muscle contraction (bronchoconstriction), increased mucus production, and recruitment of inflammatory cells to the airways. These effects contribute to the symptoms of asthma, such as wheezing, coughing, shortness of breath, and chest tightness. Zafirlukast acts by selectively blocking the CysLT1 receptors, preventing leukotrienes from binding to these receptors. By doing so, zafirlukast inhibits the inflammatory response in the airways, reduces bronchoconstriction, and helps improve asthma symptoms. It's important to note that zafirlukast specifically targets the leukotriene pathway and is not a bronchodilator. Therefore, it is not intended for immediate relief of acute asthma symptoms or as a rescue medication during an asthma attack. Short-acting bronchodilators, such as albuterol, are typically used for acute symptom relief. Zafirlukast is intended for long-term management and control of asthma symptoms.

Drug Interactions

Zafirlukast, like any medication, can potentially interact with other drugs. Here are a few examples of drug interactions that may occur with zafirlukast:

1. Theophylline: Zafirlukast may increase the blood levels of theophylline, a medication used to treat respiratory conditions. This can potentially lead to an increased risk of theophylline-related side effects. Close monitoring of theophylline levels and adjustments in dosage may be necessary.

2. Warfarin: Zafirlukast may inhibit the breakdown of warfarin, an anticoagulant medication, potentially leading to an increased risk of bleeding. Regular monitoring of blood clotting parameters (INR) is essential if these medications are used together.

3. Aspirin and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Zafirlukast may interact with aspirin or NSAIDs, such as ibuprofen or naproxen, and increase the risk of adverse effects, including the development of bronchospasm (narrowing of the airways) in patients with asthma. Avoiding concurrent use or using caution under medical supervision is recommended.

4. Propranolol: Zafirlukast may increase the blood levels of propranolol, a beta-blocker used to treat various conditions, such as high blood pressure and migraines. Close monitoring of blood pressure and heart rate is important when using these medications together.

5. Certain antibiotics: Zafirlukast may potentially interact with some antibiotics, such as erythromycin and clarithromycin, and increase the blood levels of zafirlukast. Monitoring for increased zafirlukast-related side effects is advisable when these medications are used together.

It's important to note that this is not an exhaustive list, and other interactions may occur.

Therapeutic Uses

Zafirlukast is primarily used for the long-term management and control of asthma. It is indicated for the following therapeutic uses:

1. Asthma: Zafirlukast is prescribed as an add-on therapy for the chronic treatment of asthma in adults and children aged 5 years and older. It is used in cases where asthma symptoms are not adequately controlled by other medications, such as inhaled corticosteroids alone.

2. Exercise-Induced Bronchoconstriction (EIB): Zafirlukast can be used to prevent exercise-induced bronchoconstriction, which is a temporary narrowing of the airways that occurs during or after physical activity. It is taken prior to exercise to help prevent asthma symptoms triggered by exercise.

It's important to note that zafirlukast is not intended for the relief of acute asthma symptoms or as a rescue medication during an asthma attack. Short-acting bronchodilators, such as albuterol, are typically used for immediate symptom relief.

Side Effects

Zafirlukast, like any medication, can cause side effects. Not everyone experiences these side effects, and their severity can vary from person to person. Common side effects of zafirlukast may include:

1. Headache

2. Gastrointestinal disturbances, such as nausea, diarrhea, or stomach pain

3. Infections of the upper respiratory tract, such as the common cold

4. Flu-like symptoms, including fever, chills, and body aches

5. Abnormal liver function tests (rare)

It's important to contact a healthcare professional if you experience any side effects while taking zafirlukast, as they can provide guidance on managing or adjusting your treatment.

In rare cases, zafirlukast may cause more serious side effects.

1. Allergic reactions, such as rash, itching, swelling, severe dizziness, or difficulty breathing

2. Unexplained muscle pain or weakness

3. Yellowing of the skin or eyes (jaundice)

4. Signs of liver problems, including persistent nausea, vomiting, abdominal pain, or dark urine

This is not a complete list of side effects, and others may occur.

Contraindications

Zafirlukast has certain contraindications, which are situations or conditions in which the use of the medication is not recommended due to potential risks. The contraindications of zafirlukast include:

1. Hypersensitivity: Zafirlukast is contraindicated in individuals who have a known hypersensitivity or allergy to zafirlukast or any of its components. Allergic reactions may include rash, itching, swelling, or difficulty breathing.

2. Severe liver impairment: Zafirlukast is contraindicated in patients with severe liver impairment or active liver disease. Zafirlukast is metabolized in the liver, and impaired liver function can affect the clearance of the drug and increase the risk of adverse effects.

It's important to inform your healthcare professional about any pre-existing medical conditions you have, especially liver disease, to determine if zafirlukast is safe for you to use.